COTA expands clinicogenomics offering with Genomic Testing Cooperative partnership.

cota-pattern

Bringing clarity to cancer

We are working to ensure that everyone touched by cancer has a clear path to the right care.
cota-pattern

Our Approach

We combine oncology expertise with advanced technology and analytics to organize real world data in order to guide decisions and actions.

Together, we can bring clarity to cancer care.

#6846 - COTA Healthcare homepage redesign - Providers

Providers

We curate EHR data that can be used to drive research and standardization in order to improve patient outcomes while also reducing costs at your institution.

#6846 - COTA Healthcare homepage redesign - Payers

Payers

We make clinical sense of claims data, providing insight into performance and related outcomes across sites in order to support value-based payment models.

#6846 - COTA Healthcare homepage redesign - Life Sciences

Life Sciences

Our deeply curated real world data accelerates drug development informing the decisions and actions that will deliver the best drugs to patients faster and at a lower cost.

592A2E0D_22 - COTA - Real World Talk - Seshamalini Srinivasan, Karla Feghali, Mandy Kelly, Laura Fernandes - Thumbnail

Using Fit-for-Purpose Data to Improve Patient Outcomes With Seshamalini Srinivasan, Karla Feghali, Mandy Kelly, Laura Fernandes

In the world of clinical trials, having a well-defined research question is key. And that’s where fit-for-purpose data sets come in. But what are the factors for defining research questions?

In this episode of the Real World Talk podcast, we get to hear from Seshamalini Srinivasan, Karla Feghali, Mandy Kelly, and Laura Fernandes. They talk about the criteria for defining research questions, the importance of fit-for-purpose data, and the other factors to consider in real-world data sources.

Latest Resources

The two companies are joining forces to integrate COTA’s deep clinical oncology real-world data with GTC’s comprehensive genomics testing data.

In Move to Power Precision Oncology for Patients, COTA and Genomic Testing Cooperative Form New Data Partnership

The two companies are joining forces to integrate COTA’s deep clinical oncology real-world data with GTC’s comprehensive genomics testing data.

COTA, Inc. Forms Strategic Real-World Data Research Partnership with the Clinical Research Data Sharing Alliance

COTA, Inc. is now a proud member of the Clinical Research Data Sharing Alliance (CRDSA). This cross-industry alliance is dedicated to accelerating the discovery and delivery of life-saving therapies through the use of high-quality clinical trials and real-world data.

What Makes a Fit-for-Purpose Database for Clinical Oncology Research?

A fit-for-purpose database includes key variables, reliable and accurate data, and representative samples that can be used to draw meaningful conclusions. RWD can be highly valuable in supporting clinical oncology research, but choosing the right data is essential. The keys to finding the right fit-for-purpose database include relevance, reliability, integrity, and bias.

Let’s work together to transform cancer care.

Subscribe for Updates

Receive our latest news and research from thought leaders in the RWD industry
  • This field is for validation purposes and should be left unchanged.